Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 46   

Articles published

ARNA 1.48 -0.04 (-2.63%)
price chart
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) Fights for Share of Weight-loss Pill ...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA, ARNA message board) is expected to launch its patented Belviq treatment early next year, but there are some doubts that by that time Vivus, Inc. (NASDAQ:VVUS) will have made its Qsymia something of a ...
Arena: DEA Schedule IV Will Make Belviq The Obesity Blockbuster Drug
Retail investors were right and Wall Street was wrong about the approval of Arena Pharmaceuticals' (NASDAQ:ARNA) lead drug candidate Belviq (Lorcaserin).
Obesity Drugs Gain Attention on FDA Backing for Therapies
Third Rock Ventures is an early backer of Zafgen Inc., a biotechnology company in mid-stage trials of a therapy to treat obesity. The Food and Drug Administration cleared Belviq, from Arena Pharmaceuticals Inc. and Eisai Co., in June and Vivus Inc.'s ...
Promentis receives grant to develop schizophrenia drugs
Milwaukee-based Promentis Pharmaceuticals Inc. has received a three-year, $1.8 million award from the National Institutes of Health to develop more effective drugs to treat schizophrenia.
The Rev. Sun Myung Moon to be laid to rest in South Korea
Up to 30,000 people are expected to gather in Cheongpyeong, South Korea, on Saturday for the funeral of the Rev. Sun Myung Moon, the controversial founder of the Unification Church who died this month.
Dr. Jean-Paul Castaigne, CEO of Angiochem
Yet the most exciting developments for Angiochem this year have been in the rare-diseases arena. The company raised its profile and brought publicity to its preclinical efforts in transporting enzyme drugs for orphan disorders into the brain in ...
UW foundation sees severe drop in drug licensing income
Also, DeLuca has a drug development company called Deltanoid Pharmaceuticals that "is a very valuable company," Gulbrandsen said. WARF has other pharmaceuticals that have shown promise, although not on the order of Zemplar, and start-ups like ...
Ten Pharmaceutical Companies Unite to Accelerate Development of New Medicines
Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech a member of the Roche Group, and Sanofi launched TransCelerate BioPharma Inc. ("TransCelerate"), the largest ...
10 pharma giants form nonprofit to gang up on common R&D foes  FierceBiotech
Not Another 'Rabbi for Obama'
At this moment, there are over 600 rabbis signed on as “Rabbis for Obama.” But Rabbi David Wolpe, who will be delivering a benediction Wednesday night at the Democratic National Convention, isn't one of them.
Trying on Accents Like Hats: Foreign Accent Syndrome Is a Real Psychological ...
British singer George Michael may have suffered from FAS. Michael almost died of pneumonia last year, said he was unable to talk in his usual London twang accent for two days after gaining consciousness and his family feared he'd be stuck with his new ...